Young adults researching medical cannabis need a careful mental-health screening conversation. That is not because every young adult is unsuitable. It is because age, brain development, previous cannabis exposure, anxiety, PTSD, ADHD, substance use, family history and psychosis vulnerability can change the risk picture.
The right tone is neither panic nor broad reassurance. Cannabis can affect mood, perception, anxiety, concentration and alertness. RCPsych warns that cannabis can be linked with mental-health harms, including psychosis risk, especially where other risk factors are present. Prescribed medical cannabis is assessed differently from non-prescribed use, but it still needs careful clinical judgement.
This guide is for UK patients aged roughly 18 to mid-twenties, and for families or carers supporting them. It is not medical advice, it does not recommend a product, dose, route, clinic or pharmacy, and it does not replace a psychiatrist, GP, pharmacist or specialist prescriber. For related MCPH context, read medical cannabis and mental health screening and medical cannabis for anxiety.
The short answer
If you are a young adult, be open about your mental-health history before medical cannabis is considered. Do not hide non-prescribed cannabis use, previous panic, paranoia, hallucinations, substance use, severe anxiety, self-harm, mania, bipolar disorder, psychosis symptoms or family history because you are worried it will block access.
The prescriber may need to ask about:
- anxiety, panic, depression and suicidal thoughts;
- PTSD, dissociation, trauma symptoms and sleep problems;
- ADHD symptoms, stimulant medicines and impulsivity;
- autism, eating problems, OCD or other coexisting conditions;
- psychosis, paranoia, hallucinations, unusual beliefs, mania or bipolar disorder;
- personal or family history of schizophrenia, bipolar disorder or psychosis;
- alcohol, nicotine, stimulants, cocaine, ketamine, opioids, benzodiazepines or other substance use;
- previous non-prescribed cannabis, CBD or THC reactions;
- current medicines and recent medicine changes;
- support network, work, education, driving and safeguarding context.
This is not a moral test. It is a safety screen.
Why young-adult screening is different
Mental-health screening matters at any age, but it often needs more care in younger adults because many psychiatric conditions first become visible in adolescence or early adulthood. Some people are still working out whether symptoms are anxiety, trauma, ADHD, depression, bipolar disorder, substance-use harm, autism-related distress, sleep deprivation or something else.
That overlap matters. A young adult may ask about medical cannabis for anxiety, pain, sleep or PTSD, while also having ADHD symptoms, stimulant treatment, past panic after cannabis, heavy alcohol use, family psychosis history or recent crisis-team contact. None of those details should be treated casually.
The clinician’s job is not simply to confirm the condition named on a form. It is to assess whether a cannabis-based medicinal product could be appropriate in the context of that person’s risks, medicines, previous treatments, support and monitoring.
Psychosis history and family history
Psychosis can involve hearing or seeing things that other people do not, feeling watched or controlled, believing things that others find unusual or frightening, or becoming very suspicious or detached from reality. NHS psychosis guidance treats these experiences as needing proper medical assessment.
Tell the clinic if you have ever had:
- hallucinations, paranoia or delusional beliefs;
- a diagnosis of psychosis, schizophrenia, bipolar disorder or mania;
- a hospital admission, crisis-team contact or antipsychotic treatment;
- severe sleep deprivation with unusual beliefs or behaviour;
- cannabis, stimulant or other drug use that triggered paranoia, panic or hallucinations;
- a close family history of psychosis, schizophrenia or bipolar disorder.
Do not assume a family history automatically answers the prescribing question either way. It is a risk factor for the prescriber to assess. The article cannot decide what that means for you.
Anxiety, PTSD and ADHD overlap
Anxiety, PTSD and ADHD can overlap in messy real life. A person might describe racing thoughts, poor sleep, panic, irritability, flashbacks, low mood, concentration problems, sensory overload, impulsivity or emotional swings. Cannabis may feel calming to some people and unsettling to others. THC-containing products can also worsen anxiety, paranoia, dissociation or impairment for some patients.
For anxiety or PTSD, the clinic should understand:
- what symptoms are being targeted;
- what has already been tried, helped, failed or caused problems;
- whether there is dissociation, self-harm, severe depression, suicidality or unstable symptoms;
- whether trauma therapy, medication, sleep support or crisis planning is involved.
For ADHD or possible ADHD, the clinic should understand:
- stimulant or non-stimulant medicines;
- sleep, appetite, anxiety and substance-use history;
- impulsivity, risk-taking, driving and work or education demands;
- whether symptoms are stable enough for a controlled-medicine plan.
This is not about denying that young adults may have real symptoms. It is about making sure the assessment looks at the whole pattern.
Substance use and previous cannabis reactions
Be honest about current and previous cannabis use, even if it was non-prescribed. Prior cannabis use does not mean a UK clinician will decide prescribed medical cannabis is suitable. It also does not mean you are automatically excluded. It gives the prescriber evidence about tolerance, adverse reactions, dependence risk, mental-health effects and safety.
Tell the clinic about:
- how often you use cannabis, if you do;
- whether you use high-strength products, concentrates, vapes, edibles or unknown products;
- panic, paranoia, hallucinations, dissociation, vomiting, blackouts or severe anxiety after cannabis;
- attempts to cut down, cravings or using more than intended;
- alcohol, nicotine, stimulant, cocaine, ketamine, opioid, benzodiazepine or other substance use;
- mixing cannabis with alcohol or sedating medicines.
The useful action is honesty, not performing the “right” answer.
Medicines, monitoring and support
NHS medical cannabis guidance says CBD and THC can affect how other medicines work. Young adults may be taking antidepressants, ADHD medicines, antipsychotics, mood stabilisers, sleep medicines, pain medicines, hormones, epilepsy medicines or over-the-counter products. The pharmacist and prescriber need the full list.
Monitoring should also be practical. Ask who to contact if anxiety worsens, sleep collapses, paranoia appears, mood becomes unusually elevated, suicidal thoughts return, side effects feel frightening, or family members notice behaviour changes.
If there are immediate concerns about self-harm, suicide risk, psychosis, violence, collapse, severe intoxication or a life-threatening emergency, seek urgent help through NHS 111, local crisis support, A&E or 999 as appropriate.
Questions to ask the clinic
- How do you screen young adults for psychosis, bipolar disorder, severe anxiety and substance-use risk?
- How do you handle family history of psychosis or bipolar disorder?
- What would make you decide the risk is too high?
- How do you separate anxiety, PTSD, ADHD, sleep problems and substance-use effects?
- Which medicines or supplements need pharmacist review?
- How will mental health be monitored after any prescribing decision?
- Who can I contact if paranoia, panic, hallucinations, severe mood change or suicidal thoughts appear?
- Do you need information from my GP surgery, mental-health team, university support, carer or family member?
The aim is not to talk your way into treatment. The aim is to make sure a young-adult risk decision is honest, specific and reviewed.
What this article is not saying
This article is not saying young adults cannot be prescribed medical cannabis. It is not saying medical cannabis is safe for young adults with anxiety, PTSD, ADHD or past cannabis use. It is not saying a diagnosis, family history or previous cannabis use gives a simple yes or no answer.
It is saying that young-adult mental-health screening needs to be taken seriously, especially where psychosis history, family history, anxiety, PTSD, ADHD overlap, substance use, self-harm, severe depression, bipolar risk or previous adverse cannabis reactions are part of the picture.
Sources
- NHS: Medical cannabis
- NHS: Psychosis overview
- NHS: Schizophrenia causes
- RCPsych: Cannabis and mental health
- RCPsych: Cannabis and mental health information for young people
- NICE: Cannabis-based medicinal products, NG144
- NHS England: Cannabis-based products for medicinal use
- GMC: Information for doctors on cannabis-based products for medicinal use
- CQC: Cannabis-based medicinal products: what we look at when we register
- GOV.UK: Drug driving law
